(D47.3) Essential (haemorrhagic) thrombocythaemia

Essential (haemorrhagic) thrombocythaemia is a rare blood disorder caused by an overproduction of platelets, the cells that help the blood to clot. this overproduction leads to a thickening of the blood, which can cause spontaneous bleeding and clotting.

Essential (haemorrhagic) thrombocythemia is a disorder caused by an overproduction of platelets from the bone marrow. this is caused by an abnormal proliferation of megakaryocytes, the cells that produce platelets. this overproduction of platelets leads to an increased risk of clotting, which can cause a variety of symptoms including fatigue, headaches, and bleeding. the cause of the disorder is unknown, but it is believed to be related to genetic and environmental factors.

More details coming soon

Main Goal of the Treatment: To reduce the number of platelets in the blood and reduce the risk of clotting.

• Prescribe medications to reduce platelet production
• Administer platelet-reducing drugs
• Perform regular blood tests to monitor platelet levels
• Provide lifestyle advice to reduce the risk of clotting
• Recommend a diet low in saturated fat and cholesterol
• Encourage regular exercise
• Advise against smoking
• Provide anticoagulant medications to reduce the risk of clotting
• Refer to a hematologist for further evaluation and treatment

Essential thrombocythaemia can be prevented by avoiding smoking, maintaining a healthy diet and weight, managing stress, avoiding alcohol, and controlling other chronic conditions such as diabetes and hypertension. regular exercise and avoiding contact with people who have infections can also help reduce the risk of developing this disease.